GENOSITY INC.

ASTRA NEXT

Diagnostic apparatus for the detection of cancer, namely, a molecular test intended to assess the presence or absence of residual disease at various time points during an individual's disease management;

ASTRA NEXT

Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at various time points during an individual's disease management;

ASTRA NEXT HEME

Diagnostic apparatus for the detection of cancer, namely, a molecular test intended to assess the presence or absence of residual disease at various time points during an individual's hematologic cancer management;HEME;

ASTRA NEXT HEME

Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at various time points during an individual's hematologic cancer management;HEME;

ASTRA ONE

Diagnostic apparatus for the detection of cancer, namely, a molecular test intended to assess the presence or absence of residual disease at an individual's initial management timepoint;

ASTRA ONE

Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at an individual's initial management timepoint;

ASTRA ONE HEME

Diagnostic apparatus for the detection of cancer, namely, a molecular test intended to assess the presence or absence of residual disease at an individual's initial timepoint for hematologic cancer management;HEME;

ASTRA ONE HEME

Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at an individual's initial timepoint for hematologic cancer management;HEME;

ASTRA PROFILE

Diagnostic apparatus for the detection of cancer, namely, a molecular test intended to identify a tumor molecular profile for an individual undergoing disease management;PROFILE;

ASTRA PROFILE

Diagnostic testing for the detection of cancer, namely, molecular testing intended to identify a tumor molecular profile for an individual undergoing disease management;

COMPLEXOME

COMPL EXOME;Genetic testing for medical purposes in the nature of molecular genetic testing;Medical laboratory services in the nature of molecular genetic testing for research purposes;

GENOSITY

Structural and functional analysis of genomes for medical or clinical purposes, namely, genomic sequencing, analysis of genomic sequences, correlation of genomic sequencing results to clinical data, and facilitating the rendering, displaying, analysis and interpretation of genetic data;Structural and functional analysis of genomes for scientific or research purposes, namely, genomic sequencing, analysis of genomic sequences, correlation of genomic sequencing results to clinical data, and facilitating the rendering, displaying, analysis and interpretation of genetic data;